Do you struggle with ECZEMA?
Local research study • Investigational medication • Compensation for time & travel
The COMPASS 2-AD Study - Now Enrolling
Who can participate? Adults (18 – 75 years) who have moderate to severe eczema, also known as atopic dermatitis.
What is the purpose of the study? Millions of adults struggle with eczema and the constant battle against skin irritation. While daily eczema creams are common, they do not work for everyone and can sometimes cause uncomfortable skin conditions and other side effects. This is why doctors and researchers are working to develop new medications that may better treat eczema in the future. This study is evaluating an investigational eczema medication delivered as an injection at the doctor’s office.
How long does the study last? The study lasts about 9 months and involves regular visits to your local study doctor’s office (about once every 2 weeks). These visits allow your doctor to closely monitor your progress and discuss your overall experiences.
Where? The study is being offered at select locations in Canada and the US.
Is there any cost to me? No, if you qualify and chose to join the study, you will receive all study-related care and study medication at no cost.
Will I be reimbursed for my participation? Yes, participants will be compensated for their time and travel to attend required study visits.
See If You Qualify
To see if you might qualify, and to get connected with your local study site to learn more, please take the pre-screening questionnaire below: